D-1019-2018 Class II Terminated

Recalled by Hetero Labs, Ltd. - Unit III — Hyderabad, N/A

FDA drug recall D-1019-2018 was initiated by Hetero Labs, Ltd. - Unit III on Jul 18, 2018 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules. The recall status is terminated (terminated Jul 15, 2021). Affected quantity: 18,288 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2018
Initiation Date
Jul 18, 2018
Termination Date
Jul 15, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,288 bottles

Product description

Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854; By: Hetero, Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India; NDC 31722-543-01.

Reason for recall

Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.

Distribution pattern

Nationwide in the USA

Code information

Lot #: E180315, Exp 12/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1019-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1019-2018. Report a data issue: hello@regdatalab.com.